Scheidhauer K - Search Results

1

Misalignment in PET/CT: relevance for SUV and therapy management.

Bundschuh RA, Martinez-Möller A, Ziegler SI, Schwaiger M, Scheidhauer K. Bundschuh RA, et al. Among authors: scheidhauer k. Nuklearmedizin. 2008;47(2):N14-5. Nuklearmedizin. 2008. PMID: 18589491 No abstract available.

2

[External therapy with radioactive urine: a pitfall during sceletal scintigraphy].

Scheidhauer K, Urbannek V. Scheidhauer K, et al. Nuklearmedizin. 1997 Dec;36(8):292-4. Nuklearmedizin. 1997. PMID: 17068881 German.

3

[Somatostatin receptor PET/CT (SSTR-PET/CT)].

Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A. Boy C, et al. Among authors: scheidhauer k. Nuklearmedizin. 2018 Feb;57(1):4-17. doi: 10.1055/s-0038-1636560. Epub 2018 Feb 21. Nuklearmedizin. 2018. PMID: 29536494 German.

4

Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.

Grgic A, Nestle U, Scheidhauer K, Puskas C, Ballek E, Hohloch K, Schubert J, König J, Pinkert J, Truemper L, Hellwig D, Kirsch CM. Grgic A, et al. Among authors: scheidhauer k. Nuklearmedizin. 2011;50(1):39-47. doi: 10.3413/nukmed-0322-10-06. Epub 2010 Nov 8. Nuklearmedizin. 2011. PMID: 21057722

5

Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.

Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, Schicha H, Heiss WD, Ebmeier K. Herholz K, et al. Among authors: scheidhauer k. J Nucl Med. 2002 Jan;43(1):21-6. J Nucl Med. 2002. PMID: 11801698

6

Sensitivity of PET/MRI to detect recurrence of prostate cancer.

Arce-Calisaya P, Souvatzoglou M, Eiber M, Beer A, Scheidhauer K, Geinitz H, Schwaiger M. Arce-Calisaya P, et al. Among authors: scheidhauer k. Eur J Nucl Med Mol Imaging. 2013 May;40(5):799. doi: 10.1007/s00259-013-2353-7. Epub 2013 Feb 22. Eur J Nucl Med Mol Imaging. 2013. PMID: 23429932 No abstract available.

7

Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.

Miederer M, Seidl S, Buck A, Scheidhauer K, Wester HJ, Schwaiger M, Perren A. Miederer M, et al. Among authors: scheidhauer k. Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):48-52. doi: 10.1007/s00259-008-0944-5. Epub 2008 Sep 20. Eur J Nucl Med Mol Imaging. 2009. PMID: 18807033

8

SPECT/CT.

Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Buck AK, et al. Among authors: scheidhauer k. J Nucl Med. 2008 Aug;49(8):1305-19. doi: 10.2967/jnumed.107.050195. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632825

9

Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?

Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Dietlein M, et al. Among authors: scheidhauer k. Nuklearmedizin. 1998 Jan;37(1):12-7. Nuklearmedizin. 1998. PMID: 9467164

10

Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study.

Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack HJ. Grünwald F, et al. Among authors: scheidhauer k. Eur J Nucl Med. 1999 Dec;26(12):1547-52. doi: 10.1007/s002590050493. Eur J Nucl Med. 1999. PMID: 10638405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results